Volume 21, Issue 6 pp. 632-641

Low-temperature particulate calcium phosphates for bone regeneration

M. V. F. Araújo

M. V. F. Araújo

Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON, Canada M5G 1G6

Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, Canada M5S 3G9.

Search for more papers by this author
V. C. Mendes

V. C. Mendes

Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON, Canada M5G 1G6

Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, Canada M5S 3G9.

Search for more papers by this author
P. Chattopadhyay

P. Chattopadhyay

Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON, Canada M5G 1G6

Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, Canada M5S 3G9.

Search for more papers by this author
J. E. Davies

J. E. Davies

Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, ON, Canada M5G 1G6

Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON, Canada M5S 3G9.

Search for more papers by this author
First published: 11 May 2010
Citations: 13
Correspondence to:
J. E. Davies
Institute of Biomaterials and Biomedical Engineering
University of Toronto
164 College Street
Toronto, ON
Canada M5S 3G9
Tel.: (416) 978 1471
Fax: (416) 946 5639
e-mail: [email protected]

Abstract

Background: Low-temperature synthesized calcium phosphates are produced by mixing calcium phosphate powders in an aqueous solution resulting in a precipitated phase. These compounds can be formulated in several forms (e.g. injectable cements and implantable blocks), and are commonly used as bone substitutes and drug delivery systems for the treatment of bone defects. As bone substitutes, calcium phosphates in general offer the advantages of being biocompatible and osteoconductive.

Aims: The present work employed a machine-based process to derive a reproducible preparation method for low-temperature calcium phosphate particulate (LTCP). The in vivo outcomes of LTCP were compared with those of three commercially available bone substitutes by histomorphometric measurements of bone formation and material degradation in a rat femur implantation model.

Materials & Methods: Specifically, LTCP, anorganic bovine bone (AB), bioactive glass (BG), and demineralized bone matrix (DBM) were implanted in defects created in the distal aspect of rat femora. Reparative bone and particulate volumes of these biomaterials were evaluated post-operatively using micro-computed tomography and histological analyses at 3, 6, 12, and 16 weeks.

Results & Discussion: Results showed that, despite invoking bone formation, AB, BG, and DBM were found un-resorbed in situ at 16 weeks. Conversely, LTCP showed an early increase in bone formation as well as clear evidence of complete degradation and reparative bone remodelling, resulting in the total reconstitution of the marrow cavity and marrow tissue.

Conclusion: LTCP promoted increased early bone formation, associated with an improved degradation rate, compared with the other three bone-substitute biomaterials tested.

To cite this article:
Araújo MVF, Mendes VC, Chattopadhyay P, Davies JE. Low-temperature particulate calcium phosphates for bone regeneration.
Clin. Oral Impl. Res. 21, 2010; 632–641.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.